Refreshing results…
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance
UploadNKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division
UploadIL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors
Download from doi.orgOvercoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors
Download from doi.orgThe PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
UploadLack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy
Download from doi.orgThe NKG2A - HLA-E axis as a novel checkpoint in the tumor microenvironment
Download from aacrjournals.orgVaccination against non-mutated neoantigens induced in recurrent and future tumors
UploadFuture Challenges in Cancer Resistance to Immunotherapy
Download from doi.orgTumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity
Download from doi.orgDo GNAQ and GNA11 Differentially Affect Inflammation and HLA Expression in Uveal Melanoma?
Download from doi.orgMissing publications? Search for publications with a matching author name.